Introduction {#S0001}
============

Substance abuse is a major health problem worldwide and has been linked to several neuropsychiatric disorders, gastrointestinal diseases, cancer, cardiovascular diseases, fetal alcohol syndrome, pre-term birth complications and diabetes mellitus (Chesher et al., [@CIT0006]). Genetic, biological and environmental factors could all together influence the development of alcohol and substance abuse (Tarter, [@CIT0031]). Substance abuse disorders are often difficult to treat and relapse rates are high, even when successful detoxification is followed by pharmacotherapeutic or psychotherapeutic interventions (Garner, [@CIT0012]).

Critical Aspects of Drug and Alcohol Dependence {#S0002}
===============================================

A recent important paper on the neurobiology of alcohol dependence (Koob, 2011) describes an Addiction Cycle in alcohol dependent patients, which consists of three phases, namely the binge/intoxication phase, the withdrawal/negative affect phase and the preoccupation/ anticipation phase. Further, before becoming dependent, this cycle is usually repeated multiple times. Although other neurotransmitter systems can be involved as well, the dopaminergic system is the key player in all these phases (Kalsi et al., [@CIT0020]). Alcohol addicted patients display a deregulated dopaminergic system, which results in stronger alcohol orientation and loss in interest for natural rewards. Because of this malfunctioning dopaminergic system alcoholic patients encounter difficulties in learning new reward associated stimuli and they lack motivation to seek new rewarding stimuli (Heinz et al., [@CIT0014]). Once 'addiction' is established, the cycle is characterized by impulsivity and compulsivity (Koob & Volkow [@CIT0023]).

Main Cognitive Targets For Therapeutic Interventions In Drug And Alcohol Dependence {#S0003}
===================================================================================

Impulsivity is characterized by non planned reactions to external and internal stimuli and it is associated with positive reinforcement (Zhang et al. [@CIT0032]). The underlying neurobiology of impulsivity in alcohol dependency is complex (Potenza and Taylor, [@CIT0026]). The prefrontal cortical network, and in particular the dorsolateral prefrontal cortex (DLPFC) and the orbitofrontal cortex (OFC) play an important role in inhibitory control mechanisms when patients are confronted with addictive substances (Bechara [@CIT0004]; Schoenbaum et al., [@CIT0027]). Increasing the activity of the PFC and thus cognitive control could decrease automatic impulses and therefore reduce substance abuse behavior (Houben et al., [@CIT0018]). Next to the deregulation of the dopaminergic system, the hypothalamus-pituitary-adrenal (HPA) axis is dysfunctional (Koob & Volkow [@CIT0023], Sinha et al., [@CIT0028]).

Recently, neuromodulation techniques, such as transcranial magnetic stimulation (TMS) have been applied to substance abuse and alcohol dependent patients (Barr et al., [@CIT0003]). However, to date no clear guidelines in alcohol addiction are at hand to determine when such interventions can be applied. Therefore, the purpose of this review is to critically evaluate the efficacy of TMS in the treatment of alcohol dependence and other substance abuse disorders.

Method of Conducting this Review {#S0004}
================================

We conducted a broad search on electronic databases such as PubMed and the Cochrane Library. We used PubMed search terms were alcohol dependence, craving, addiction, cocaine abuse, nicotine dependence and transcranial magnetic stimulation. Only articles written in English were taken into account. Systematic reviews and meta-analysis were also analysed and relevant articles were chosen for this study.

Repetitive Transcranial Magnetic Stimulation (Rtms) in The Treatment of Alcohol Dependence {#S0005}
==========================================================================================

rTMS can alter cortical excitability, and hence induce changes in neuronal circuits (Fitzgerald et al., [@CIT0011], Cho & Strafella, [@CIT0007]). rTMS is also able to influence the HPA-axis (Baeken et al., 2011). With this technique, the DLPFC is the preferred stimulation place for the rTMS application in alcohol dependency (Bechara, [@CIT0004], Mishra et al., [@CIT0024]). rTMS has the capacity to modulate decision-making in healthy individuals and it is hypothesized that this neuromodulation technique can change impulsivity in addicted individuals (Fecteau et al., [@CIT0010]).

In a recent study authors (Heremans et al., [@CIT0015]) stimulated thirty-six recently detoxified alcohol-dependent patients with one sham-controlled high-frequency (HF)rTMS session delivered on the right DLPFC. Alcohol craving was evaluated and measured with the Obsessive Compulsive Drinking Scale (OCDS). Immediate effects were registered in the lab setting without cue exposure, while long-term effects were evaluated in patients' natural environment. The lack of effect in subjective craving measurements was explained by the absence of cue reactivity and because not all alcoholic patients do experience craving when confronted with alcohol cues (Ooteman et al., [@CIT0025]).

In a case report, a 48-year-old woman with a treatmentresistant alcohol dependence problem was stimulated with low-frequency (LF)-rTMS during an active drinking period (De Ridder et al., [@CIT0009]). The frontal cortex was stimulated with a double cone coil. A double cone coil is able to modulate both dorsal and subcallosal ACC, both important in craving. The patient was stimulated during 5 weeks. During the treatment craving measurements were suppressed and remained so until three months after stimulation. Authors (Mishra et al., [@CIT0024]) have performed a sham-controlled study with ten daily sessions of HF-rTMS on the right DLPFC in forty-five alcohol-dependent patients. Craving was evaluated before the first and after the last stimulation session with the Alcohol Craving Questionnaire (ACQ-NOW). Real rTMS was significantly superior in decreasing craving measurements compared to sham stimulation. Craving measurements were evaluated until 4 weeks after stimulation. After four weeks however, there were no significant differences between the active and the sham group, which might imply that the effects are waning after a couple of weeks.

Höppner et al. [@CIT0017] stimulated nineteen detoxified alcohol-dependent female patients at the left DLPFC during 10 days with HF-rTMS in a sham-controlled design. Although no differences were found in craving measurements with the OCDS, they found an alteration in the attentional blink (AB) paradigm. According to the authors this alteration in the AB could be a physiological parable for craving reduction. However, patients did not acknowledge a decrease in subjective craving. Research on rTMS in alcohol dependence is still relatively scarce and over the different studies there is a considerable variability in methodology. Therefore it is difficult to draw firm conclusions. Stimulation parameters, such as frequency, % of motor threshold, train duration, inter-train interval and laterality of stimulation differ significantly among studies. Until now, there are no fixed stimulation protocols in alcohol addiction. Research on the effect of rTMS on impulsivity is inconclusive and as to which hemisphere needs to be stimulated remains to be determined. The use of multiple sessions may prove to be more effective in decreasing craving. We suggest the evaluation of multiple rTMS sessions in larger, randomized, sham controlled population samples. Studies should also be done to evaluate whether patients need stimulation with high or low frequency.

Repetitive Transcranial Magnetic Stimulation in other Substance Abuse Disorders {#S0006}
===============================================================================

Recently, Camprodon and colleagues (2007) examined rTMS as a potential treatment for the cravings experienced by cocaine-dependent individuals. In this randomized cross-over design, two sessions of 10 Hz rTMS was administered to the right and left DLPFC at 90% RMT. Visual analogue scales were administered to obtain level of cocaine cravings 10 minutes before, immediately, and 4 hours following rTMS treatment. RTMS applied to the right, but not the left DLPFC, was found to decrease subjects' level of cravings for cocaine with these differences existing between baseline and immediately after rTMS session, and baseline and 4 hours post rTMS session.

Moreover, as rTMS applied to the DLPFC has been shown to induce DA release in the subcortical structures and the caudate nucleus (Strafella et al., [@CIT0030]), these findings provide a possible mechanism through which the cravings associated with chronic use of cocaine are reduced (Goldstein and Volkow, [@CIT0013]).

Although several treatments including buproprion, varenicline, nicotine nicotine chewing gum, nicotine skin patch, nicotine nasal spray and lozenges and psychosocial as well as behavior therapy, are proven to be approximately double to triple the rate of smoking cessation (Siu and Tyndale, [@CIT0029]), an effective treatment is still needed to target the altered neurotransmission resulting from chronic nicotine dependence. In this regard, rTMS applied to frontal regions has been shown to increase the release of DA in rats (Keck et al., [@CIT0021]) and in humans (Strafella et al., [@CIT0030]) associated with enhanced GABAB receptor activity (Daskalakis et al., 2006). Repetitive TMS applied to the DLPFC, therefore, shows promise as an effective treatment in nicotine dependence. The Eichammer group (Hoffmann et al., [@CIT0016]) were the first to examine the efficacy of rTMS as a potential treatment in nicotine dependence. In the first pilot double-blind cross-over study, 11 smoking dependent individuals who hoped to stop smoking were administered either active or sham rTMS over the left DLPFC at 90% of RMT. In the individuals who received active high-frequency rTMS over the DLPFC reported significantly reduced levels in smoking cravings 30 minutes following the treatment as compared to those who received sham stimulation. These findings, therefore, motivated further examination of rTMS' potential in the treatment of nicotine dependence in smokers with aims to reduce not only the level of cravings but also smoking consumption. In the second double-blind cross-over design study, 14 individuals who wished to stop smoking were administered 2 active, and 2 placebo-control sham rTMS in a randomized order for 4 consecutive days. High-frequency (20 Hz) rTMS was applied to the left DLPFC at an intensity of 90% RMT, and smoking cravings were measured at baseline and 30 minutes after the rTMS session using a 100-point visual analogue scale. During this 6 hour time period, the number of cigarettes smoked following rTMS applied to the left DLPFC was significantly decreased, with no change in the level of cravings. Treatment with high-frequency rTMS was, therefore, found to reduce the level of cravings for cigarettes in the pilot study, although this finding was not replicated in the second study. A similar out patient study stimulating the DLPFC with HF-rTMS has also shown to attenuate nicotine craving (Amiaz et al., [@CIT0001]).

Limitations of Studies and Future Directions {#S0007}
============================================

Repetitive TMS has been shown to induce cortical changes in preclinical and clinical investigations through its effects on neurotransmission (Daslakis et al., [@CIT0008]). The treatment studies that examined the efficacy of rTMS in the treatment of cocaine and nicotine dependence in are the first in this field. Although the reviewed work represents promise in the use of rTMS in the treatment of substance abuse, certain limitations must be addressed. First, the use of larger sample sizes in the examination of rTMS as a potential treatment in persons with substance abuse with aims to reduce the level of cravings and consumption would strengthen this preliminary evidence with increased statistical power. Second, the studies reviewed here are limited to the short-term effects of rTMS on the level of cravings and consumption, and fail to examine the efficacy of rTMS' long-term effects and its potential to achieve abstinence. In addition, preclinical studies using animal models to examine the efficacy of rTMS in the treatment of substance abuse represents an area that needs to be further explored.

###### 

Summary of major studies of rTMS in Substance Abuse and Alcohol Dependence

  ------------------------------------------------------------------------------------------------------------------------------
  STUDY DETAILS                      METHODS                                    RESULTS
  ---------------------------------- ------------------------------------------ ------------------------------------------------
  **Alcohol Dependence**                                                        

  **Bechara 2005**                   DLPFC 10 sessionsHF-rTMS                   Decreased craving

  **Mishra et al.,2010**\            DLPFC 10 sessions HF-rTMS                  Decreased carving Attenuates Attentional Blink
  **Hoppner et al., 2011**\                                                     
  **Heremans et al.,** [@CIT0015]                                               

  **Substance Abuse**                                                           

  **Camprodon et al.,** [@CIT0005]   Cocaine dependence HF DLPFC stimulation    Decreased cocaine craving

  **Hoffman et al., 2003**\          Nicotine dependence HF DLPFC stimulation   Attenuates nicotine craving
  **Amiaz et al., 2009**                                                        
  ------------------------------------------------------------------------------------------------------------------------------

Conclusions {#S0008}
===========

Transcranial magnetic stimulation has provided a safe and non-invasive method to evaluate the neurophysiology of the human cortex. Moreover, TMS has shown promise in the diagnosis of several patient populations, including SUDs. Although, this research remains in its infancy, TMS paradigms have demonstrated alterations in cortical excitation in chronic cocaine, nicotine, and alcohol users. Moreover, rTMS has been reported to modulate neurotransmission, and early studies suggest that it may be a promising treatment for a number of substance abuse disorders.
